Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 (2019-nCoV) S2 | monoclonal | Recombinant Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) S2 | polyclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Casirivimab | monoclonal | Recombinant Human | n/a | affinity purified | 50 µg, 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Imdevimab | monoclonal | Recombinant Human | n/a | affinity purified | 50 µg, 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 (2019-nCoV) NSP1 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV-2 variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV-2, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) RBD | monoclonal | Recombinant Mouse | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) S | polyclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
NSP10 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP3 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP4 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP7 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP8 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP9 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
SARS-CoV-2 S RBD | monoclonal | Recombinant Human | SARS-CoV, SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 S1 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 S RBD | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
Envelope Protein (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
Membrane Protein (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
Membrane Protein (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP13 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP14 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
NSP16 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
SARS-CoV-2 Surface Glycoprotein | 004 | Recombinant | SARS-CoV-2, HCoV-HKU1 (isolate N1); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |